Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
| Status: | Completed |
|---|---|
| Conditions: | Gastroesophageal Reflux Disease , Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2007 |
| End Date: | April 2008 |
The investigators hypothesized that:
1) an intervention targeted at the prescribing physician would increase the rate of a
metoclopramide discontinuation among patients prescribed the medication for questionable or
unclear indications; and 2) the discontinuation would be durable.
1) an intervention targeted at the prescribing physician would increase the rate of a
metoclopramide discontinuation among patients prescribed the medication for questionable or
unclear indications; and 2) the discontinuation would be durable.
Inclusion Criteria:
- Physicians at University of Pennsylvania Health System who ordered an active
metoclopramide prescription with a questionable indication.
Exclusion Criteria:
- Physicians-in-training (e.g., residents, fellows)
- Physicians how were investigators on this study
- Physicians serving on the the University of Pennsylvania Drug Use and Effects
Committee or Information Technology Oversight Board
We found this trial at
1
site
Philadelphia, Pennsylvania 19104
Click here to add this to my saved trials
